HILLEN WOLFGANG has a total of 12 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Germany. Its main competitors in its focus markets biotechnology and pharmaceuticals are REED THOMAS D, BEIJING BIOHEALTHCARE BIOTECHNOLOGY CO LTD and BIOCENTURY TRANSGENE (CHINA) CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | Germany | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Measuring microorganism processes | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hillen Wolfgang | 12 |
#2 | Bujard Hermann | 2 |
#3 | Berens Christian | 1 |
#4 | Klolzsche Marcus | 1 |
#5 | Henssler Eva | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005123923A2 | Inducer specific tetracycline repressor proteins and methods of use thereof | |
WO03056021A2 | Modified tetracycline repressor protein compositions and methods of use | |
AU5417700A | Method for identifying novel transcriptional regulatory proteins | |
AU5419100A | Novel TET repressor-based transcriptional regulatory proteins | |
DE19851415A1 | Mutant transactivator | |
DE19851413A1 | Procedure for selecting mutants of tTA or rtTA |